Sort
40,608 grants matching “prostate cancer”
Role of MED1 in the AR-dependent transcription in advanced prostate cancer
$364,284Irfan Ahmed Asangani · University Of Pennsylvania · R01 · FY2023 · CA
Clinical Trials with Immunotoxins
$364,272Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Targeted delivery of multimodal therapy for reducing prostate cancer disparity
$364,267Runhua Runa Liu · University Of Alabama At Birmingham · R01 · FY2024 · CA
Culture of tumor versus normal cells
$364,140Tan A. Ince · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Culture of tumor versus normal cells
$364,140Tan A. Ince · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Low-rank Approximation to Probe-level Data with Application to Exon Tiling Arrays
$364,139Jianhua Hu · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · GM
Inhibition of CDK5 as a Treatment for Pancreatic Cancer
$364,128Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2014 · CA
Inhibition of CDK5 as a Treatment for Pancreatic Cancer
$364,128Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2016 · CA
Elucidating the Role of Trop2 in Prostate Cancer
$364,090Tanya I Stoyanova · Stanford University · R37 · FY2022 · CA
Biomarkers for Prostate and Bladder Cancer
$364,050University Of Washington · U01 · FY2004 · CA
Proteomic, Glycomic and Autoantibody Lung Cancer Biomarker Validation
$364,038Paul D Lampe · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA
Evaluation of Immune-based Combinations in Metastatic Prostate Cancer
$364,008Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Nrf2, immune cells and lung cancer
$364,001Karen T. Liby · Michigan State University · R01 · FY2019 · CA
Novel Therapeutic Approaches for Aggressive Prostate Cancer
$363,999Arthur M Mercurio · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · CA
Inside-Out Nonlinear Gradients to Improve Diffusion MRI
$363,999Gigi Galiana · Yale University · R01 · FY2024 · CA
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER
$363,990University Of Maryland Baltimore · R01 · FY2002 · CA
Project 1: Targeting the MYC Pathway in Prostate Cancer
$363,968Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2021 · CA
AR gene rearrangements and AR signaling in prostate cancer
$363,908Scott M. Dehm · University Of Minnesota · R01 · FY2021 · CA
AR gene rearrangements and AR signaling in prostate cancer
$363,908Scott M. Dehm · University Of Minnesota · R01 · FY2020 · CA
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines
$363,877Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Molecular Pathology of Cancer
$363,876Michael Emmert-Buck · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$363,871James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The development of Saccharomyces (yeast) vaccines for cancer therapy
$363,871James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Targeting Endoplasmic Reticulum Stress Response for Cancer Therapy
$363,859Bertal H. Aktas · Harvard Medical School · R01 · FY2011 · CA
Internet-Based Education for Prostate Cancer Screening
$363,858Kathryn L Taylor · Georgetown University · R01 · FY2008 · CA